{"data":[{"accessionNo":"0000093751-26-000530","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS INC","ticker":"RXRX","cusip":"75629V104","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":34706130,"percentOfClass":6.6,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0002100121-26-000994","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001601830","issuerName":"Recursion Pharmaceuticals Inc","ticker":"RXRX","cusip":"75629V104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":31369274,"percentOfClass":5.97,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0002100119-26-001441","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001601830","issuerName":"Recursion Pharmaceuticals Inc","ticker":"RXRX","cusip":"75629V104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":26744129,"percentOfClass":5.09,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0002012383-26-002868","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":"75629V104","securityClass":"Class A Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":44541605,"percentOfClass":8.5,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0000093751-26-000285","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS INC","ticker":"RXRX","cusip":"75629V104","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":28490638,"percentOfClass":5.5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0002012383-26-001465","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":"75629V104","securityClass":"Class A Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":37821797,"percentOfClass":7.2,"filedAt":"2026-04-24","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0000102909-26-002160","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001601830","issuerName":"Recursion Pharmaceuticals Inc","ticker":"RXRX","cusip":"75629V104","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001088875-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"BAILLIE GIFFORD & CO","reportingCik":null,"personType":"IA","sharesOwned":23774972,"percentOfClass":4.6,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001104659-26-009588","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"Recursion Pharmaceuticals, Inc.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":37316856,"percentOfClass":7.25,"filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001104659-26-009588","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"Recursion Pharmaceuticals, Inc.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":37316856,"percentOfClass":7.25,"filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"MDC Capital Partners (Ventures), LP","reportingCik":"0001714230","personType":"PN","sharesOwned":7062869,"percentOfClass":1.4,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"MDC Capital Partners (Ventures) GP, LP","reportingCik":null,"personType":"PN","sharesOwned":7062869,"percentOfClass":1.4,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"MIC Capital Management UK LLP","reportingCik":"0001889830","personType":"IA","sharesOwned":2581164,"percentOfClass":0.5,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"MC Alternative Solutions, LP","reportingCik":"0001974767","personType":"PN","sharesOwned":1388889,"percentOfClass":0.3,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp","reportingCik":null,"personType":"OO","sharesOwned":1192275,"percentOfClass":0.2,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"Mubadala Investment Co PJSC","reportingCik":"0001704268","personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},{"accessionNo":"0001999371-25-021183","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001601830","issuerName":"RECURSION PHARMACEUTICALS, INC.","ticker":"RXRX","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2024-11-20","reportingPerson":"Mamoura Diversified Global Holding PJSC","reportingCik":"0001419351","personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-23","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"}],"updatedAt":"2026-10-29T09:49:47.335Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}